Compare Emerson Electric Co. (EMR) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Emerson Electric Co. vs Summit Therapeutics Inc — how do they compare? Emerson Electric Co. trades at $163.97 (market cap $91.37B), while Summit Therapeutics Inc trades at $13.97 (market cap $12.06B). The key difference: Emerson Electric Co. is far larger — about 7.6× Summit Therapeutics Inc's market cap, and Emerson Electric Co. pays a 1.36% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| EMR | SMMT | |
|---|---|---|
Market Cap | $91.37B | $12.06B |
Sector | Industrials | Health |
52-Week High | $164.38 | $26.98 |
52-Week Low | $123.30 | $12.55 |
Enterprise Value | $102.44B | $11.39B |
Dividend Yield | 1.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Emerson Electric (EMR) trades at $164.19, down slightly by 0.11% on the day, with a bullish technical outlook as it hovers near pivot point resistance. The company reported strong Q2 2026 earnings, beating EPS estimates with $1.71 versus $1.68 expected, driven by 7% revenue growth and robust performance in Software & Systems. Recent acquisitions and AI initiatives, such as the Glue Inc. purchase, highlight strategic expansion. Valuation ratios like a P/E of 35.84 and P/S of 4.95 reflect premium pricing amid solid profitability, with a net income margin of 13.83%.
EMR's outlook is positive, supported by raised 2026 guidance and analyst consensus favoring a buy rating with a $171.33 price target. Key opportunities include organic growth in automation and AI integration, but risks involve high valuation sensitivity and macroeconomic pressures on industrial demand. Cash flow volatility from recent net outflows requires monitoring for sustainability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Emerson Electric Co.
Emerson Electric is a multi-industrial conglomerate that operates under two business platforms: automation solutions and commercial and residential solutions. The latter is further subdivided into two operating segments: climate technologies, which sells HVAC and refrigeration products and services as well as tools and home products, which sells tools and compressors, among other products and services. Commercial and residential solutions boasts several household brands, including Copeland and RIDGID. Automation solutions is most known for its process manufacturing solutions, which consists of measurement instrumentation, as well as valves and actuators, among other products and services. Roughly half of the firm's geographic sales take place in the United States.
Read more on EMR →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
